Methods Of Using Sustained Release Aminopyridine Compositions

Patent No. EP1732548 (titled "Methods Of Using Sustained Release Aminopyridine Compositions") was filed by Acorda Therapeutics on Apr 11, 2005. The application was issued on Aug 30, 2023.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_0003290/2026Sep 14, 2026Aliud Pharma, StadapharmRevocation

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NEURAXPHARM ARZNEIMITTELMar 8, 2012KONIGER
SYNTHONMar 7, 2012BENNEKER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1732548

ACORDA THERAPEUTICS
Application Number
EP05732613A
Filing Date
Apr 11, 2005
Status
Patent Maintained As Amended
Jul 28, 2023
Publication Date
Aug 30, 2023